Mirjam H. Koster

818 total citations
21 papers, 515 citations indexed

About

Mirjam H. Koster is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Mirjam H. Koster has authored 21 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Mirjam H. Koster's work include Drug Transport and Resistance Mechanisms (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Cholesterol and Lipid Metabolism (3 papers). Mirjam H. Koster is often cited by papers focused on Drug Transport and Resistance Mechanisms (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Cholesterol and Lipid Metabolism (3 papers). Mirjam H. Koster collaborates with scholars based in Netherlands, United States and France. Mirjam H. Koster's co-authors include Alain de Bruin, Niels Kloosterhuis, Bart van de Sluis, Folkert Kuipers, Debby P.Y. Koonen, Barbara M. Bakker, Marten H. Hofker, Daphne Dekker, Martijn van Faassen and Jingyuan Fu and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Circulation Research.

In The Last Decade

Mirjam H. Koster

19 papers receiving 509 citations

Peers

Mirjam H. Koster
Daphne Dekker Netherlands
Mengjuan Xue China
Eaum Seok Lee South Korea
Liu Gao China
Kazuki Kakimoto Japan
Tilo Wuensch Germany
Herbert Tilg Austria
Daphne Dekker Netherlands
Mirjam H. Koster
Citations per year, relative to Mirjam H. Koster Mirjam H. Koster (= 1×) peers Daphne Dekker

Countries citing papers authored by Mirjam H. Koster

Since Specialization
Citations

This map shows the geographic impact of Mirjam H. Koster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjam H. Koster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjam H. Koster more than expected).

Fields of papers citing papers by Mirjam H. Koster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirjam H. Koster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjam H. Koster. The network helps show where Mirjam H. Koster may publish in the future.

Co-authorship network of co-authors of Mirjam H. Koster

This figure shows the co-authorship network connecting the top 25 collaborators of Mirjam H. Koster. A scholar is included among the top collaborators of Mirjam H. Koster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirjam H. Koster. Mirjam H. Koster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eijgenraam, Tim R., Niels Kloosterhuis, Rick Havinga, et al.. (2025). The impact of a humanized bile acid composition on atherosclerosis development in hypercholesterolaemic Cyp2c70 knockout mice. Scientific Reports. 15(1). 2100–2100. 2 indexed citations
2.
Kloosterhuis, Niels, Nicolette Huijkman, Marieke Smit, et al.. (2024). ERICH4 is not involved in the assembly and secretion of intestinal lipoproteins. Atherosclerosis. 399. 118635–118635.
3.
Halmos, Balázs, Mirjam H. Koster, Niels Kloosterhuis, et al.. (2024). Deficiency of Abca1 and Abcg1 mediated cholesterol efflux pathways in smooth muscle cells enhances vasoconstriction but does not affect atherosclerosis. Cardiovascular Research. 120(Supplement_1). 1 indexed citations
4.
Smit, Marieke, Martijn Koehorst, Mirjam H. Koster, et al.. (2023). Changes in bile acid composition are correlated with reduced intestinal cholesterol uptake in intestine-specific WASH-deficient mice. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1869(2). 159445–159445.
5.
Yu, Lei, Vincent W. Bloks, Hong Yang, et al.. (2023). Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia. SHILAP Revista de lepidopterología. 11(1). 5–5. 1 indexed citations
6.
Kruit, Janine K., Rick Havinga, Mirjam H. Koster, et al.. (2023). The chemotherapeutic drug doxorubicin does not exacerbate p16Ink4a-positive senescent cell accumulation and cardiometabolic disease development in young adult female LDLR-deficient mice. Toxicology and Applied Pharmacology. 468. 116531–116531. 3 indexed citations
7.
Koster, Mirjam H., Niels Kloosterhuis, Marieke Smit, et al.. (2022). Increased atherosclerosis in a mouse model of glycogen storage disease type 1a. Molecular Genetics and Metabolism Reports. 31. 100872–100872. 1 indexed citations
8.
Versloot, Christian J., Miriam Langelaar‐Makkinje, Albert Gerding, et al.. (2022). Organoids as a model to study intestinal and liver dysfunction in severe malnutrition. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1869(3). 166635–166635. 8 indexed citations
9.
Schukken, Klaske M., Petra L. Bakker, Mirjam H. Koster, et al.. (2021). Acute systemic loss of Mad2 leads to intestinal atrophy in adult mice. Scientific Reports. 11(1). 68–68. 3 indexed citations
10.
Gruben, Nanda, Leen Catrysse, Martijn Koehorst, et al.. (2021). The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis. Molecular Metabolism. 54. 101349–101349. 55 indexed citations
11.
Derks, Terry G. J., Nicolette Huijkman, Trijnie Bos, et al.. (2021). Modeling Phenotypic Heterogeneity of Glycogen Storage Disease Type 1a Liver Disease in Mice by Somatic CRISPR/CRISPR‐associated protein 9–Mediated Gene Editing. Hepatology. 74(5). 2491–2507. 9 indexed citations
12.
Vieira‐Lara, Marcel A., Theo H. van Dijk, Henk Wolters, et al.. (2020). Short‐term protein restriction at advanced age stimulates FGF21 signalling, energy expenditure and browning of white adipose tissue. FEBS Journal. 288(7). 2257–2277. 21 indexed citations
13.
Heijning, Bert J. M. van de, Alain de Bruin, Rachel Thomas, et al.. (2020). Spontaneous liver disease in wild-type C57BL/6JOlaHsd mice fed semisynthetic diet. PLoS ONE. 15(9). e0232069–e0232069. 4 indexed citations
14.
Hartgers, Merel L., Laurens F. Reeskamp, Antoine Rimbert, et al.. (2020). Taking One Step Back in Familial Hypercholesterolemia. Arteriosclerosis Thrombosis and Vascular Biology. 40(4). 973–985. 32 indexed citations
15.
Toussaint, M.J.M., Laura Bongiovanni, Mirjam H. Koster, et al.. (2020). E2F7 Is a Potent Inhibitor of Liver Tumor Growth in Adult Mice. Hepatology. 73(1). 303–317. 20 indexed citations
16.
Hulzebos, Christian V., Martijn van Faassen, Ido P. Kema, et al.. (2019). LED-phototherapy does not induce oxidative DNA damage in hyperbilirubinemic Gunn rats. Pediatric Research. 85(7). 1041–1047. 7 indexed citations
17.
Brandsma, Eelke, Niels Kloosterhuis, Mirjam H. Koster, et al.. (2019). A Proinflammatory Gut Microbiota Increases Systemic Inflammation and Accelerates Atherosclerosis. Circulation Research. 124(1). 94–100. 289 indexed citations
18.
Chen, Lianmin, Sanzhima Garmaeva, Shixian Hu, et al.. (2019). Omeprazole-Induced Dysbiosis Impacts Bile Acid Metabolism In Mice And Humans. Atherosclerosis. 287. e120–e120. 1 indexed citations
19.
Wijshake, Tobias, Janine K. Kruit, Nicolette Huijkman, et al.. (2017). NF-κB p65 serine 467 phosphorylation sensitizes mice to weight gain and TNFα-or diet-induced inflammation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1864(10). 1785–1798. 9 indexed citations
20.
Toussaint, M.J.M., Klaas M. Govaert, Sathidpak Nantasanti, et al.. (2016). Surgical resection and radiofrequency ablation initiate cancer in cytokeratin-19+- liver cells deficient for p53 and Rb. Oncotarget. 7(34). 54662–54675. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daphne Dekker Breakdown of academic impact, for papers by Mengjuan Xue Breakdown of academic impact, for papers by Eaum Seok Lee Breakdown of academic impact, for papers by Liu Gao Breakdown of academic impact, for papers by Kazuki Kakimoto Breakdown of academic impact, for papers by Tilo Wuensch Breakdown of academic impact, for papers by Herbert Tilg
Rankless by CCL
2026